Over the course of the past decade, Demir has been equal parts visionary and cheerleader for health tech efforts. Prior to his Novartis tenure, Demir created a host of online marketing campaigns for Bayer and Pfizer all around the world, including tough-to-break and often neglected markets such as the Middle East and Africa.
For Bayer, Demir led a successful effort to add social media to the company’s hematology marketing playbook. Speaking at Digital Pharma East, he discussed the thought and planning that went into the first Facebook ad with scrolling important safety information, which included a call now button for Betaseron, a drug used to treat symptoms of relapsing multiple sclerosis.
However, his advocacy of all things health tech is no less notable. Demir was one of the first high-level execs to push for the adoption of new, boundary-pushing tactics both publicly and zealously. To that end, he has served as a guest lecturer at Brown University to explore the use of artificial intelligence as well as data mining and analytics in healthcare.